Bay Area's Principia Biopharma Scores $765M MS Licensing Deal With Drug Giant Sanofi Post author:Sam Post published:November 8, 2017 Post category:BioPharma Sanofi will write a check for $40 million upfront. Source: BioSpace You Might Also Like Biogen's CSO Quietly Leaves, But Will Still Get R&D Funding From the Biotech Giant May 14, 2017 Zoetis Awards Scholarships To Rising Veterinary Students March 19, 2017 CardioFocus Announces European CE Mark Approval Of The Next-Generation HeartLight Excalibur Balloon Designed For The Treatment Of Atrial Fibrillation September 26, 2017
CardioFocus Announces European CE Mark Approval Of The Next-Generation HeartLight Excalibur Balloon Designed For The Treatment Of Atrial Fibrillation September 26, 2017